{"task_id": "f408c93d053f84cf", "source": "Approach to Internal Medicine_ A Resource Book for Clinical Practice ( PDFDrive ).pdf (Part 173/464)", "text": "(cont\u2019d)\nApproach to Anticoagulation Therapies\n161\n\n--- Page 183 ---\nCORRECTION OF SUPRATHERAPEUTIC INR DUE TO\nWARFARIN USE (CONT\u2019D)\nINR 5 9\nif no significant bleeding, hold the\nnext 1 2 doses of warfarin or omit the next dose\nof warfarin and administer vitamin K1 2.5 mg PO. If\nrapid reversal required (e.g. bleeding or urgent\nsurgery), FFP 10 20 mL/kg + vitamin K1 2 4 mg\nPO (# INR within 24 h), if INR remains high at 24 h,\ngive additional vitamin K1 1 2 mg PO. May also\nconsider\nprothromin\ncomplex\nconcentrate\nin\nselected cases\nINR >9\nif no significant bleeding, hold warfarin and\nadminister vitamin K1 5 10 mg PO. Use additional\nvitamin K1 if indicated by frequent INR monitoring. If\nserious bleeding, hold warfarin, administer FFP\n20 30 mL/kg + vitamin K1 10 mg by slow IV infusion.\nAlso can use prothrombin complex concentrate or\nrecombinant factor VIIa, depending on volume status\nand urgency. If life threatening bleeding, hold warfarin\ntherapy and administer recombinant factor VIIa, FFP,\nand vitamin K1 10 mg by slow IV infusion. Monitor INR\nand repeat as necessary. May also consider prothromin\ncomplex concentrate in selected cases\nTransfusion Reactions\nCOMPLICATIONS OF TRANSFUSIONS\nAdverse Effect\nPathophysiology\nOnset and Symptoms\nTreatments\nABO\nincompatibility\nRecipient Ab against donor RBC\nmajor antigen, 1/40,000\nImmediate. Fever, # BP,\nCP, lumbar pain,\nhemoglobinuria, and\nbleed\nStop transfusion and check\nblood. Fluids, diuretics,\nFFP, dialysis\nAcute hemolytic\nreaction\nRecipient Ab against donor RBC\nminor antigen, 1/600,000\nAcute/delay. Milder form\nof above\nStop transfusion and check\nblood. Fluids, diuretics,\nFFP, dialysis\nFebrile reaction\nRecipient Ab against donor\nWBC\nPRBC, 1/300; or platelets (5U),\n1/10\nEnd of transfusion. Fever,\nchills\nAntihistamine\n(diphenhydramine\n50 mg IV \u00031 dose),\nacetaminophen\nAnaphylaxis\nRecipient Ab against donor IgA,\n1/40,000\nImmediate. # BP,\nbronchospasm, no fever\nStop transfusion,\nepinephrine,\ncorticosteroids\nUrticaria\nRecipient IgE against donor\nantigens, 1/100 plasma\ncontaining products\nAcute. Pruritic rash\nAntihistamine\n(diphenhydramine\n50 mg IV \u00031 dose)\nPost transfusion\npurpura (PTP)\nRecipient Ab against donor\nplatelet\n7 10 days after.\nConsumptive\nthrombocytopenia and\npurpura\nSteroids, plasmapheresis\nTransfusion\nassociated\ncirculatory\noverload (TACO)\nHypervolemia\n1/700\nAcute/delay. Pulmonary\nedema\nEpinephrine,\ncorticosteroids\nSeptic transfusion\nPlatelets (5 U) 1/10,000 risk of\nsymptomatic sepsis and\n1/40,000 chance of death\nPRBC (1 U), 1/100,000 risk of\nsymptomatic sepsis and\n1/500,000 chance of death\nAcute. Fever, # BP\nStop transfusion, empiric\nantibiotics\nAir embolism\nAcute. SOB, # BP\nSupportive measures\nTRALI\nDonor Ab against recipient\nWBC, 1/5000 plasma\ncontaining products\nAcute. Hypoxemic,\npulmonary edema\nSupportive measures\nGVHD\nDonor lymphocytes against\nrecipient tissue\nDelay. Rash, hepatitis,\ndiarrhea\nInfection risk\nHIV 1/10 million, HCV 1/3 million, HBV 1/72,000, HTLV1 1/2 million, West Nile virus\n< 1/1 million\nCORRECTION OF SUPRATHERAPEUTIC INR DUE TO\nWARFARIN USE (CONT\u2019D)\n162\nTransfusion Reactions", "text_length": 3096, "metadata": {"source": "Approach to Internal Medicine_ A Resource Book for Clinical Practice ( PDFDrive ).pdf (Part 173/464)", "type": "chunk", "chunk_index": 172, "total_chunks": 464, "uploaded_by": "admin@admin.com", "upload_date": "2025-12-11T18:40:09.483659", "document_uuid": "fda2cab4-cdd9-4015-af24-46fd62c86d94", "filename": "Approach to Internal Medicine_ A Resource Book for Clinical Practice ( PDFDrive ).pdf", "category": "medical_pdf", "section": "body", "year": null, "outdated": false, "document_id": "fda2cab4-cdd9-4015-af24-46fd62c86d94"}, "created_at": "2025-12-11T18:40:09.484363", "status": "complete", "chunks_added": 2}